PDD (NASDAQ:PDD – Get Free Report) and PetMed Express (NASDAQ:PETS – Get Free Report) are both retail/wholesale companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations.
Earnings and Valuation
This table compares PDD and PetMed Express”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PDD | $61.75 billion | 2.18 | $13.99 billion | $9.40 | 10.06 |
| PetMed Express | $226.97 million | 0.20 | -$6.27 million | ($3.12) | -0.68 |
Analyst Ratings
This is a breakdown of current recommendations and price targets for PDD and PetMed Express, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| PDD | 0 | 9 | 6 | 0 | 2.40 |
| PetMed Express | 1 | 1 | 0 | 0 | 1.50 |
PDD currently has a consensus price target of $137.86, indicating a potential upside of 45.85%. Given PDD’s stronger consensus rating and higher possible upside, analysts clearly believe PDD is more favorable than PetMed Express.
Profitability
This table compares PDD and PetMed Express’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PDD | 23.01% | 26.57% | 16.99% |
| PetMed Express | -35.51% | -70.81% | -33.67% |
Institutional and Insider Ownership
39.8% of PDD shares are held by institutional investors. Comparatively, 73.3% of PetMed Express shares are held by institutional investors. 3.7% of PDD shares are held by company insiders. Comparatively, 2.0% of PetMed Express shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Volatility and Risk
PDD has a beta of 0.04, suggesting that its stock price is 96% less volatile than the S&P 500. Comparatively, PetMed Express has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.
Summary
PDD beats PetMed Express on 12 of the 14 factors compared between the two stocks.
About PDD
PDD Holdings Inc., a multinational commerce group, owns and operates a portfolio of businesses. It operates Pinduoduo, an e-commerce platform that offers products in various categories, including agricultural produce, apparel, shoes, bags, mother and childcare products, food and beverage, electronic appliances, furniture and household goods, cosmetics and other personal care, sports and fitness items and auto accessories; and Temu, an online marketplace. It focuses on bringing businesses and people into the digital economy. The company was formerly known as Pinduoduo Inc. and changed its name to PDD Holdings Inc. in February 2023. The company was incorporated in 2015 and is based in Dublin, Ireland.
About PetMed Express
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Receive News & Ratings for PDD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PDD and related companies with MarketBeat.com's FREE daily email newsletter.
